15% off first order with code: 1storder
Competitive Prices
Foxo4-DRI from Pharma Lab Global Norway is a peptide that operates by interrupting the interaction between FOXO4 and p53, two proteins that play crucial roles in cellular ageing and senescence. This interaction prompts senescent cells to self-destruct, a process known as apoptosis. Thus, Foxo4-DRI has been a significant focus for research in age-related diseases and the pursuit of understanding cellular longevity. Foxo4-Dri from Pharma Lab Global Norway is available in vials, pre-mixed pens, and nasal sprays, that offer versatile options for research applications.
Showing all 3 results
ALL PRODUCTS AVAILABLE ON THIS WEBSITE ARE FOR RESEARCH PURPOSES ONLY.
DISCLAIMER: All products on this site https://norway.pharmalabglobal.com are exclusively for research and laboratory purposes only. The products on this site are not intended for use in humans or animals, nor are they designed to diagnose, treat, cure or prevent any illness. All information and content provided on our Pharma Lab Global website are purely for educational purposes. All products are to be handled by suitably qualified and properly trained research professionals only.